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We showed [Biochem. J. (1981) 194, 99-1021 that inhibition of y-glutamyl transpeptidase in vivo with 
serine-borate d creases amino acid uptake by mammary gland. However, doubts arose about he validity 
of this inhibitor in metabolic studies because it must be used in very large amounts. New inhibitors have 
been isolated, like anthglutin and acivlcin, which are effective at low concentrations i  vivo. Here, we show 
that treatment of lactating rats with these substances decreases the transpeptidase activity and the amino 
acid uptake by the gland. These results upport he hypothesis that the y-glutamyl cycle functions as an 
amino acid transport system in mammary gland. 
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1. INTRODUCTION (ii) That unknown amounts of free serine would 
The concept of the gamma-glutamyl cycle [ 1] 
be present in the mixture of serine and borate. 
Recently new substances have been isolated that 
are inhibitors of gamma-glutamyl transpeptidase 
[7,8] and that overcome these shortcomings. 
has attracted attention because it postulates a 
mechanism for amino acid transport which con- 
sists of a series of reactions that form a metabolic 
cycle. However, this concept has been seriously 
challenged [2]. Indeed, a key enzyme, gamma- 
glutamyl transpeptidase, whose active centre faces 
the external part of the cell membrane [3], must 
react with extracellular amino acids and in- 
tracellular glutathione. Thus, direct proof of the 
role of the gamma-glutamyl cycle as an amino acid 
transport system was required [4]. 
We showed [5] that treatment of lactating rats 
with serine-borate, an inhibitor of gamma- 
glutamyl transpeptidase [6], decreases amino acid 
uptake by the gland. However, very large amounts 
of serine-borate (20 mmol/kg body wt) had to be 
used. This presents two problems: 
(i) That such large amounts might be cytotoxic 
and thus the decreased amino acid uptake 
might not represent a specific inhibition of 
gamma-glutamyl transpeptidase in vivo; 
Here we show that these substances are effective 
as inhibitors of gamma-glutamyl transpeptidase in 
mammary gland in vivo. Treatment of lactating 
rats with these specific inhibitors of gamma- 
glutamyl transpeptidase results in a decrease in up- 
take by the gland of the amino acids that are good 
substrates of gamma-glutamyl transpeptidase, 
while those which are poor substrates of the en- 
zyme are not affected, thus providing strong sup- 
port for the hypothesis that the gamma-glutamyl 
cycle functions as an amino acid transport system 
in mammary gland in vivo. 
2. MATERIALS AND METHODS 
Lactating Wistar rats at the peak of lactation 
(days lo-15 of lactation) were used. They always 
had access to food and water. 
Arteriovenous differences of amino acids were 
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obtained measuring the concentration of amino 
acids in whole blood from the pudic-epigastric vein 
and from the aorta, as in [5]. Acini from mam- 
mary glands were isolated by the method in [9], 
under the conditions in [lo]. Lipid synthesis was 
measured as in [l 11. Lactate and pyruvate were 
measured by standard enzymatic methods [ 121. 
Gamma-glutamyl transpeptidase was measured by 
following the hydrolysis of gamma-glutamyl-p- 
nitro-anilide as in [13]. 
[l-14C]Glucose was from Amersham Interna- 
tional (Bucks). Acivicin (AT-125) was obtained 
from Dr Hanka, The Upjohn Company 
(Kalamazoo MI) and anthglutin from Dr Minato, 
Sankyo Co. (Tokyo). 
We used 25 mg anthglutinikg body wt or 10 mg 
acivicin/kg body wt, injected i.p., 1 h before 
measuring the arteriovenous differences of amino 
acids. 
3. RESULTS AND DISCUSSION 
3.1. Effect of acivicin and anthglutin on gamma- 
glutamyl transpeptidase activity in mammary 
gland 
The gamma-glutamyl transpeptidase activity in 
mammary gland at the peak of lactation is 10.9 f 
1.7 (n = 8) pm01 p-nitroanilide . min-’ . g fresh 
wt-‘. When rats were injected with 10 mg/kg body 
wt acivicin, as in [14], the gamma-glutamyl 
transpeptidase activity fell to 5.7 & 2.5 (n = 5) 
pm01 .min-’ .g fresh wt-‘; i.e., 52% of the con- 
trols, in agreement with previous findings in other 
organs which showed that acivicin is an irreversible 
inhibitor of gamma-glutamyl transpeptidase. 
However, when rats were injected with 25 mg/kg 
body wt of anthglutin and gamma-glutamyl 
transpeptidase was determined in mammary gland 
homogenates, the value found was 8.8 f 2.0 (n = 
4); i.e., non-statistically different from controls. 
This may be explained by the facts that the inhibi- 
tion of gamma-glutamyl transpeptidase by anth- 
glutin is reversible [7] and that the concentration of 
anthglutin in the assay system containing a small 
sample of a mammary gland homogenate is very 
low. However, when 0.25 mM anthglutin, i.e., a 
concentration similar to that found in the blood of 
a 200 g rat injected with 5 mg of anthglutin, was 
added to the assay system, the gamma-glutamyl 
transpeptidase activity of mammary gland homo- 
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genates fell to 3.6 f 0.2 (n = 4) pmol .min-’ .g 
fresh wt-‘. 
Thus, both acivicin and anthglutin proved to be 
effective inhibitors of gamma-glutamyl transpep- 
tidase in mammary gland, as previously observed 
with other tissues. 
3.2. Effect of serine-borate onglucose metabolism 
in mammary gland 
In [5] we used large amounts of the complex 
serine-borate (20 mmol/kg body wt) to inhibit 
gamma-glutamyl transpeptidase in rat mammary 
gland and found that it inhibited amino acid up- 
take by the gland. However, doubts arose about 
the validity of this inhibitor in metabolic studies 
because large concentrations had to be used. In- 
deed non-specific damage to acinar cells could also 
result in a decrease in amino acid uptake. We have 
thus tested the effect of 20 mM serine-borate on 
glucose metabolism by isolated acini from mam- 
mary gland and found that when they were in- 
cubated with 5 mM [l-14C]glucose, the formation 
of lactate, pyruvate and CO2 and the incorporation 
of carbon units to lipids by the acini were not af- 
fected by incubation with 20 mM serine-borate 
(table l), thus showing that, at least in vitro, such 
large amounts of the inhibitor do not exert toxic 
effects on glucose and lipid metabolism of acinar 
cells. 
3.3. Effect of inhibition of gamma-glutamyl 
transpeptidase on amino acid uptake by 
mammary gland 
Table 2 shows that inhibition of gamma- 
glutamyl transpeptidase in mammary gland by 
treatment with acivicin or anthglutin results in a 
decrease in arteriovenous differences of amino 
acids, specially of those that are substrates of 
gamma-glutamyl transpeptidase while those that 
are not substrates of the enzyme, like the branched 
chain, the aromatic and the basic amino acids, are 
not affected. In rats treated with anthglutin, 
however, the uptake by the gland of proline, lysine 
and arginine, which are poor substrates of gamma- 
glutamyl transpeptidase, was decreased. We do not 
have an explanation for these 3 exceptions, pro- 
bably anthglutin might exert other effects apart 
from inhibiting gamma-glutamyl transpeptidase. 
However, the fact that all the amino acids that are 
good substrates of the transpeptidase are affected 
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Table 1 
Effect of serine-borate on [I-‘4C]glucose metabolism in isoIated acini from mammary glands 
of lactating rats 
Additions 14C02 
formed 
[ 14C]Lipids 
formed 
Lactate 
formed 
Pyruvate 
formed 
[ l-*4C]Glucose 0.46 f 0.09 0.27 f 0.04 0.26 f 0.11 0.07 f 0.02 
[l-*4C]Glucose + 
serine-borate 0.44 * 0.03 0.26 rt 0.02 0.33 * 0.11 0.08 + 0.02 
For details see section 2. The incubation medium contained glucose (5 mM) and serine-borate 
(20 mM). The results are mean values f SD, expressed as pmol. min-’ 1 100 mg dry wt-‘, for 
4 expt 
by anthglutin, that the majority of those that are 
not substrates are not affected and the fact that 
with acivicin, the other inhibitor used, only the 
amino acids that are good substrates of the enzyme 
are affected while those that are poor substrates 
are not, provides strong support for the theory that 
the gamma-glutamyl cycle indeed functions as an 
amino acid transport system in mammary gland. 
Recently [HI, it has been emphasized that selec- 
tive modifications of glutathione metabolism may 
Table 2 
Effects of anthglutin and acivicin on blood arteriovenous differences of amino acids across the mammary gland of 
lactating rats 
Amino acid Controls (n = 6) 
Arterial Arteriovenous 
level differences 
Anthglut~-trite (n = 4) 
Arterial Arteriovenous 
level differences 
Acivicin-treated (n = 6) 
Arterial Arteriovenous 
level differences 
L-Aspartic acid 
L-Threonine 
L-Serine 
L-Asparagine 
L-Glutamic acid 
L-Glutamine 
L-Proline 
Glycine 
L-Alanine 
L-Valine 
L-Cystine 
L-Methionine 
L-Isoleucine 
L-Leucine 
L-Tyrosine 
L-Phenyl~anine 
L-Lysine 
L-Histidine 
L-Arginine 
36i 5 
432 j, 98 
340 zk 81 
6Ort 11 
213 rt 16 
589 f 35 
266 f 49 
301 + 71 
546 f 102 
170 f 37 
137 4 15 
115 5 11 
113 f 12 
191 k 20 
123 f 21 
4lf 9 
139 f 11 
203 rt: 11 
634 2 
lo* 2 
108 zt 14 
82 f 27 
18* 6 
29It 5 
138 zt 30 
47 f 14 
58 f 15 
131 It 15 
69 r 24 
4li 8 
40f 8 
45 2 10 
71 f 20 
36+ 11 
15f 5 
29zt 5 
35k 9 
20f 4 
37 f 10 4f lb 
241 f 103 23 f 20b 
216 it 69 19 I 12a 
62zt 18 12i 4 
177 rt 62 ll* 78 
563 11: 216 52 f 20b 
203 f 52 19* 2& 
216 + 62 22 + 98 
569 zt 236 51 * 41a 
191 f 68 35 f 14 
116 f 29 23k 7 
85 zk 19 19 f 3a 
75 f 27 242 8 
164f 54 474 9 
131 + 26 14* 7 
46* 10 13+ 6 
1252 4 IS* 2b 
167 f 12 18k 7 
64* IO 10 * 3a 
41* 9 4f lb 
397 + 53 21* sb 
321 i 23 27 f 1Oa 
66+ 6 8+ 3’ 
194 f 20 llf 4b 
629 f 96 54 f lgb 
237 + 30 29* 9 
281 f 36 24 & 7b 
633 f 114 34 f 13b 
188 f 38 62zt 9 
112 + 10 17 f 3b 
90* 13 15* 4b 
8Ok 11 29zt 8 
178 -+ 26 73 + 11 
136 + 26 25+ 6 
51+- 5 16+ 6 
L-U+- 4 162 9 
184 _f- 12 24+ 11 
76 f 10 2Ok 6 
For details see text. Results are mean + SD, expressed as nmol/ml, with the numbers of experiments in parentheses. 
Arteriovenous differences that are signific~tIy different from the control are shown: * p < 0,005; b p < 0.001 
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throw light on several functions of glutathione. 
Here we show that selective inhibition of gamma- 
glutamyl transpeptidase decreases amino acid up- 
take by the gland in vivo, independently of the in- 
hibitor used. We have shown [16,17] that changes 
in gamma-glutamyl transpeptidase activity induced 
by prolactin or oestrogens are followed by parallel 
changes in amino acid uptake by the gland. This, 
together with the facts reported here, suggests that 
the regulation of gamma-glutamyl cycle as an 
amino acid transport mechanism may be exerted 
through changes in gamma-glutamyl transpep- 
tidase activity. 
The fact that the inhibition of gamma-glutamyl 
transpeptidase affects the uptake of some amino 
acids, but not all of them, emphasizes the idea that 
the gamma-glutamyl cycle may be one of the 
several amino acid transport systems that occur in 
the cell, and that its function does not exclude the 
existence of other amino acid transport 
mechanisms. 
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